Breast Cancer Risk, Cell Squeezing Technology, Microfluidics, Oncology Research, Machine Learning Healthcare, Cancer Screening, Mechanical Age Cells, Breast Cancer Diagnosis, AI in Oncology, Cell Mechanics, Predictive Medicine, Cancer Prevention, Biomedical Engineering, Clinical Innovation, Risk Assessment, oncology diagnostics innovation, cell mechanics cancer, early cancer risk detection, AI in breast cancer screening, personalized cancer risk, biomedical engineering oncology, cancer screening tools, predictive oncology
Breast Cancer Risk via Cell Squeezing Technology

Key Highlights Novel cell-squeezing technology assesses breast cancer risk at the cellular level. Microfluidic platform.

nivolumab, oral dysplasia, precancerous oral lesions, immunotherapy, checkpoint inhibitors, PD-1 inhibitor, oral cancer prevention, intralesional therapy, AACR 2026, head and neck oncology, cancer immunology, clinical trials oncology, MD Anderson research, minimally invasive oncology, tumor microenvironment, MD Anderson study, tumor immune response, CD8 T cell activation, non surgical cancer treatment, early cancer intervention, oncology clinical trial results
Nivolumab Reduces Oral Cancer Risk in Phase I Trial

Key Highlights Intralesional nivolumab reduced lesion size in 85% of patients 60% average shrinkage; 65%.

Hyperemesis Gravidarum, Pregnancy Sickness, GDF15, Genetic Study, GWAS, Maternal Health, Obstetrics, Prenatal Care, Metformin, Pregnancy Complications, severe nausea pregnancy, HG genetic study, GWAS pregnancy, maternal health research, pregnancy complications, gestational diabetes genes, nausea vomiting pregnancy, obstetrics research, prenatal genetics, metformin pregnancy trial, GFRAL receptor, HG treatment options
Hyperemesis Gravidarum Genes: Largest GWAS Study

Quick Summary Largest GWAS identifies 10 genes linked to hyperemesis gravidarum (HG) GDF15 remains the.

GLP-1, GLP-1 Drug, GLP-1 resistance, Type 2 diabetes, pharmacogenomics, PAM gene, GLP-1 receptor agonists, HbA1c, precision medicine, semaglutide, diabetes treatment, endocrinology, insulin resistance, metabolic disorders, clinical trials, diabetes drugs, genetic variants, semaglutide drugs, Ozempic effectiveness, Wegovy response, pharmacogenomics diabetes, HbA1c reduction, personalized diabetes care, insulin secretion, gastric emptying, diabetes drug response, endocrine research, precision medicine diabetes
GLP-1 Drug Effectiveness Reduced by Genetic Variants

Key Points Summary Genetic variants in the PAM enzyme may reduce response to GLP-1 receptor.

TB vaccines, tuberculosis prevention, VPM1002, Immuvac, extrapulmonary TB, pulmonary TB, latent TB infection, BCG vaccine, TB clinical trial, infectious diseases, global health, vaccine safety, pediatric TB, TB research India, immunization strategies, TB protection, pulmonary tuberculosis, latent TB infection, BCG vaccine limitations, TB prevention strategies, infectious disease research, pediatric TB protection, vaccine safety TB, TB clinical trial India, global TB burden, TB immunization
TB Vaccines Show Safety but Limited Protection in Large Trial

Key Highlights Two candidate Tuberculosis vaccines, VPM1002 and Immuvac, demonstrated strong safety profiles No overall.

Stem Cell Therapy, Parkinson’s Disease, Regenerative Medicine, Neurology Education, CME Courses, ISSCR, Harvard Medical School, Dopamine Neuron Replacement, Clinical Trials Parkinson’s, Movement Disorders, Neurology Research, Stem Cell Medicine, Physician Education, Nursing Education, Neurodegenerative Disease, ISSCR education program, neurology continuing education, stem cell medicine course, Parkinson’s disease clinical research, regenerative therapies for PD, neurology training course, stem cell research Parkinson’s, movement disorders education, healthcare professional neurology CME
Stem Cell Therapies Course for Parkinson’s Disease Clinicians

Key Summary The International Society for Stem Cell Research launched a new continuing education course.

Food tolerance, Food allergy research, Regulatory T cells, Immune tolerance, Gut immune system, Dietary proteins, Zein protein, Food allergy prevention, Stanford University research, Immunology research, Allergy treatment research, Intestinal immunity, Science Immunology study, Pediatric allergy prevention, Clinical immunology, intestinal immunity, zein protein corn, allergy immunology research, immune response to food, food allergy therapy, microbiome and immunity, clinical immunology research, tolerance peptides
Food Tolerance Mechanism: How T Cells Prevent Allergies

Key Summary Researchers at Stanford University discovered that food tolerance is an active immune process,.

Fragmentome Technology, Liver Fibrosis Detection, Cirrhosis Screening, AI Liquid Biopsy, Cell-Free DNA, cfDNA Fragmentation, Genome-Wide Sequencing, Chronic Liver Disease, Hepatology Research, Cancer Prevention, Machine Learning in Medicine, Comorbidity Index, Precision Medicine, Translational Medicine, Early Disease Detection, liver disease biomarkers, liver fibrosis blood test, machine learning in hepatology, noninvasive liver disease diagnosis, comorbidity index prediction, cirrhosis risk assessment, precision medicine liver disease, translational medicine research
Fragmentome Technology Detects Early Liver Fibrosis

Key Points at a Glance AI-based fragmentome technology detects early liver fibrosis and cirrhosis using.

Chronic GVHD, Stem Cell Transplant, Bone Marrow Transplant, AI in Transplant Medicine, Immune Biomarkers, Transplant Complications, Precision Medicine, Hematology, Oncology Research, Clinical Decision Support, transplant mortality risk, machine learning medicine, GVHD prediction, post-transplant care, precision transplant medicine, hematology oncology, clinical risk models, transplant immunology, BIOPREVENT
AI Predicts Chronic GVHD Risk After Stem Cell Transplant

Key Takeaways A new AI-driven tool, BIOPREVENT, predicts chronic GVHD and transplant-related mortality before symptoms.

Measles, Measles cases in North Carolina, MMR vaccination, Measles outbreak, Public health alert, Vaccine-preventable disease, NC Department of Health, Infectious disease update, Pediatric health, Immunization programs, Exposure notification, Airborne transmission, Measles symptoms, Outbreak dashboard, Vaccines for Children program, Community health
Rising Measles Cases Prompt Vaccination Push in NC

Key Highlights 15 confirmed Measles cases reported since late December 2025 The first hospitalization was.